Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
2.295
+0.015 (0.66%)
Nov 21, 2024, 4:00 PM EST - Market closed

Alpha Tau Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
--29.16-33.76-27.27-8.88-8.37
Depreciation & Amortization
-1.070.980.780.090.07
Stock-Based Compensation
-7.936.750.810.60.55
Other Operating Activities
--0.292.4613.290.050.91
Change in Accounts Payable
-1.140.220.240.110.15
Change in Other Net Operating Assets
-1.35-0.530.350.79-0.21
Operating Cash Flow
--17.96-23.88-11.81-7.25-6.91
Capital Expenditures
--6.4-0.9-2.93-3.77-1.29
Investment in Securities
-28.24-89.0322.2-4.05-8.87
Other Investing Activities
--3.15----
Investing Cash Flow
-18.68-89.9419.27-7.82-10.16
Long-Term Debt Issued
-5.25----
Net Debt Issued (Repaid)
-5.25----
Issuance of Common Stock
-0.053.360.110.596.27
Other Financing Activities
--93.54---0.95
Financing Cash Flow
-5.396.910.1129.325.32
Foreign Exchange Rate Adjustments
--0.05-0.260.110.08-0.02
Net Cash Flow
-5.97-17.177.6814.33-11.77
Free Cash Flow
--24.36-24.78-14.74-11.02-8.2
Free Cash Flow Per Share
--0.35-0.39-0.36-0.27-0.24
Cash Interest Paid
-0.05----
Cash Income Tax Paid
-0.020.0100-
Levered Free Cash Flow
--19.4-14.62-7.53-7.87-
Unlevered Free Cash Flow
--19.35-14.62-7.53-7.87-
Change in Net Working Capital
0.41-0.351.36-2.43-1-
Source: S&P Capital IQ. Standard template. Financial Sources.